摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基-4-嘧啶羧酸 | 933683-35-3

中文名称
5-甲基-4-嘧啶羧酸
中文别名
5-甲基嘧啶-4-甲酸
英文名称
5-methyl-pyrimidine-4-carboxylic acid
英文别名
5-Methyl-pyrimidin-4-carbonsaeure;5-Methylpyrimidine-4-carboxylic acid
5-甲基-4-嘧啶羧酸化学式
CAS
933683-35-3
化学式
C6H6N2O2
mdl
——
分子量
138.126
InChiKey
INTUWGJOBDUGLY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    316.6±22.0 °C(Predicted)
  • 密度:
    1.319±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    63.1
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933599090
  • 危险性防范说明:
    P305+P351+P338
  • 危险性描述:
    H319

SDS

SDS:25bf51f5aea1df5990457a541d05febb
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] OCTAHYDROCYCLOPENTAPYRROLES, THEIR PREPARATION AND USE<br/>[FR] OCTAHYDROCYCLOPENTAPYRROLES, LEUR PRÉPARATION ET LEUR UTILISATION
    申请人:UNIV COLUMBIA
    公开号:WO2014152018A1
    公开(公告)日:2014-09-25
    The present invention provides Octahydrocyclopentapyrrole compounds having the structure: (structurally represented) wherein psi is absent or present, and when present is a bond; R1, R2, R3, R4, and R5 are each independently H, halogen, CF, or C1-C4 alkyl; R6 is absent or present, and when present is H, OH, or halogen; A is absent or present, and when present is C(O) or C(O)NH; B is substituted or unsubstituted monocycle, bicycle, heteromonocycle, heterobicycle, benzyl, CO2H or (C1-C4 alkyl)-CO2H, wherein when B is CO2H, then A is present and is C(O); and when psi is present, then R6 is absent and when psi is absent, then R6 is present, or a pharmaceutically acceptable salt thereof, for treatement of diseases characterized by excessive lipofuscin accumulation in the retina.
    本发明提供了具有以下结构的八氢环戊吡咯化合物:(结构表示) 其中psi为不存在或存在,当存在时为键;R1、R2、R3、R4和R5各自独立为H、卤素、CF或C1-C4烷基;R6不存在或存在,当存在时为H、OH或卤素;A不存在或存在,当存在时为C(O)或C(O)NH;B为取代或未取代的单环、双环、杂单环、杂双环、苄基、CO2H或(C1-C4烷基)-CO2H,其中当B为CO2H时,A存在且为C(O);且当psi存在时,R6不存在,当psi不存在时,R6存在,或其药用可接受盐,用于治疗以视网膜过度脂褐素积聚为特征的疾病。
  • PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS
    申请人:Andrews Mark David
    公开号:US20120258950A1
    公开(公告)日:2012-10-11
    The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as Trk antagonists.
    本发明涉及式(I)化合物及其药学上可接受的盐,其中取代基如本文所述,并且它们在医学上的用途,特别是作为Trk拮抗剂。
  • Vinyl-phenyl derivatives for inflammation and immune-related uses
    申请人:Bohnert Gary
    公开号:US20070249051A1
    公开(公告)日:2007-10-25
    The invention relates to compounds of structural formula (Ia): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X 1 , X 2 , X 3 , X 4 , X 6 , X 10 , R 1 , Y, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
    该发明涉及结构式(Ia)的化合物:或其药学上可接受的盐,溶剂化合物,笼合物或前药,其中X1,X2,X3,X4,X6,X10,R1,Y,Z,L和n在此定义。这些化合物可用作免疫抑制剂,并用于治疗和预防炎症性疾病,过敏性疾病和免疫性疾病。
  • Phenyl and pyridyl compounds for inflammation and immune-related uses
    申请人:Jiang Jun
    公开号:US20070275960A1
    公开(公告)日:2007-11-29
    The invention relates to compounds of structural formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R 1 , X 1 , X 2 , Y, Z, L, and n are defined herein. The compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
    本发明涉及结构式(I)的化合物:或其药学上可接受的盐,溶剂化合物,包合物或前药,其中R1,X1,X2,Y,Z,L和n在此定义。这些化合物可用作免疫抑制剂,并用于治疗和预防炎症病症,过敏性疾病和免疫疾病。
  • VINYL-PHENYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES
    申请人:Synta Pharmaceuticals Corp.
    公开号:US20140248299A1
    公开(公告)日:2014-09-04
    The invention relates to compounds of structural formula (Ia): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X 1 , X 2 , X 3 , X 4 , X 6 , X 10 , R 1 , Y, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
    本发明涉及结构式(Ia)的化合物:或其药学上可接受的盐、溶剂化合物、笼合物或前药,其中X1、X2、X3、X4、X6、X10、R1、Y、Z、L和n在此定义。这些化合物可用作免疫抑制剂,用于治疗和预防炎症性疾病、过敏性疾病和免疫性疾病。
查看更多